US · NGVT · CHEMICALS - SPECIALTY
Ingevity Corporation (NGVT) intrinsic value and stock valuation
$53.75as of 2026-11-21 · Mkt cap 2.65B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Ingevity Corporation DCF and intrinsic value
InvestorsCraft values NGVT with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from NGVT’s statements →
Ingevity Corporation Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2012–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Elevra Lithium Limited (ELVR) $20.62
- Skeena Resources Limited (SKE) $23.83
- Ashland Inc. (ASH) $72.40
- Quaker Houghton (KWR) $147.48
- Allied Gold Corporation (AAUC) $17.80
- Minerals Technologies Inc. (MTX) $57.97
- Innospec Inc. (IOSP) $75.56
- The Chemours Company (CC) $10.88
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.17B | $1.41B | $1.69B | $1.67B | $1.39B |
| Operating income | $261.9M | $259.9M | $256.4M | $341M | $307.2M |
| Net income | -$-167.1M | -$-430.3M | -$-5.4M | $211.6M | $118.1M |
| EPSd | -$-4.62M | -$-11.85M | -$-147.95K | $5.5M | $2.95M |
| Operating cash flow | $331.2M | $128.6M | $205.1M | $313.4M | $293.3M |
| Capital expenditure | -$-57.7M | -$-77.6M | -$-109.8M | -$-142.5M | -$-103.8M |
| Free cash flow | $273.5M | $51M | $95.3M | $170.9M | $189.5M |
| Total assets | $1.65B | $2.02B | $2.62B | $2.74B | $2.47B |
| Total debt | $1.24B | $1.45B | $1.53B | $1.53B | $1.32B |
| Net debt | $1.16B | $1.39B | $1.44B | $1.45B | $1.05B |
| Total equity | $29.7M | $195.2M | $631.4M | $698.3M | $673.8M |
| Cash and short-term investments | $78.1M | $68M | $95.9M | $76.7M | $275.4M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.17B | $1.41B | $1.69B | $1.67B | $1.39B |
| Cost of revenue | $706.1M | $951.7M | $1.22B | $1.1B | $878.7M |
| Gross profit | $461.5M | $454.7M | $471.9M | $570.1M | $512.8M |
| Research and development expenses | $28.4M | $28.1M | $31.8M | $30.3M | $26.3M |
| Selling, general and administrative expenses | $171.2M | $166.7M | $183.7M | $198.8M | $179.3M |
| Other expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $199.6M | $194.8M | $215.5M | $229.1M | $205.6M |
| Cost and expenses | $905.7M | $1.15B | $1.44B | $1.33B | $1.08B |
| Interest income | $4.4M | $6.9M | $6.3M | $5.8M | $4M |
| Interest expense | $77.1M | $97.8M | $93.3M | $61.8M | $51.7M |
| Depreciation and amortization | $106.4M | $108.3M | $122.8M | $108.8M | $109.9M |
| Ebitda | $37.4M | -$-329.5M | $206M | $440.2M | $324.4M |
| Operating income | $261.9M | $259.9M | $256.4M | $341M | $307.2M |
| Total other income/expenses, net | -$-404M | -$-795.5M | -$-266.5M | -$-71.4M | -$-144.4M |
| Income before tax | -$-142.1M | -$-535.6M | -$-10.1M | $269.6M | $162.8M |
| Income tax expense | $8.2M | -$-105.3M | -$-4.7M | $58M | $44.7M |
| Net income | -$-167.1M | -$-430.3M | -$-5.4M | $211.6M | $118.1M |
| Weighted average shares outstanding | $36.2M | $36.3M | $36.5M | $38.5M | $39.8M |
| Weighted average diluted shares outstanding | $36.2M | $36.3M | $36.5M | $38.5M | $40.1M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $78.1M | $68M | $95.9M | $76.7M | $275.4M |
| Net receivables | $157.8M | $162.7M | $211M | $249.3M | $191.4M |
| Inventory | $186M | $195.9M | $308.8M | $335M | $241.2M |
| Total current assets | $454.2M | $493.2M | $658.6M | $683.3M | $724.9M |
| Property, plant and equipment, net | $637.6M | $687.6M | $829.3M | $855.2M | $772.1M |
| Goodwill and intangible assets | $219.8M | $499.1M | $912.8M | $974.3M | $820.7M |
| Long-term investments | $83.1M | $87.3M | $99.2M | $109.8M | $35.3M |
| Total non-current assets | $1.2B | $1.53B | $1.96B | $2.05B | $1.74B |
| Total assets | $1.65B | $2.02B | $2.62B | $2.74B | $2.47B |
| Accounts payable | $92M | $94.5M | $158.4M | $174.8M | $125.8M |
| Short-term debt | $58.9M | $78.2M | $103.1M | $17.4M | $37M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $341.3M | $264.1M | $362.9M | $303.5M | $268.9M |
| Long-term debt | $1.18B | $1.38B | $1.43B | $1.51B | $1.29B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $1.28B | $1.56B | $1.63B | $1.73B | $1.53B |
| Capital lease obligations | $131.8M | $152.6M | $67.3M | $57.3M | $53.6M |
| Total liabilities | $1.62B | $1.83B | $1.99B | $2.04B | $1.8B |
| Common stock | $400K | $400K | $400K | $400K | $400K |
| Retained earnings | $404.9M | $572M | $1B | $1.01B | $796.1M |
| Accumulated other comprehensive income (loss) | $500K | -$-41.4M | -$-26.7M | -$-46.8M | $13.1M |
| Total equity | $29.7M | $195.2M | $631.4M | $698.3M | $673.8M |
| Total investments | $83.1M | $87.3M | $99.2M | $109.8M | $35.3M |
| Total debt | $1.24B | $1.45B | $1.53B | $1.53B | $1.32B |
| Net debt | $1.16B | $1.39B | $1.44B | $1.45B | $1.05B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-167.1M | -$-430.3M | -$-5.4M | $211.6M | $118.1M |
| Depreciation and amortization | $106.4M | $108.3M | $122.8M | $108.8M | $109.9M |
| Stock-based compensation | $18.3M | $11.9M | $10.6M | $16.1M | $12.3M |
| Change in working capital | $22.7M | -$-10M | -$-67.8M | -$-66.5M | $30.5M |
| Accounts receivable | $12.2M | $38.2M | $42.7M | -$-42.1M | -$-13.8M |
| Inventory | $40.2M | $86.2M | $25.8M | -$-63.7M | -$-55.8M |
| Accounts payable | -$-2.6M | -$-63.4M | -$-14.6M | $42.7M | $14.8M |
| Net cash provided by operating activities | $331.2M | $128.6M | $205.1M | $313.4M | $293.3M |
| Investments in property, plant and equipment | -$-57.7M | -$-77.6M | -$-109.8M | -$-142.5M | -$-103.8M |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | -$-344.5M | $0.00 |
| Net cash used for investing activities | -$-57.5M | -$-79.5M | -$-77.3M | -$-551.9M | -$-138.6M |
| Common stock issued | $1.4M | $0.00 | $4.7M | $0.00 | $4.7M |
| Common stock repurchased | -$-56.3M | $0.00 | -$-92.1M | -$-145.2M | -$-109.4M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-252.2M | -$-70.2M | -$-99.9M | $48.1M | -$-133.1M |
| Net change in cash | $26M | -$-25.3M | $27.6M | -$-196.4M | $19.9M |
| Cash at end of period | $112.6M | $86.6M | $111.9M | $84.3M | $280.7M |
| Operating cash flow | $331.2M | $128.6M | $205.1M | $313.4M | $293.3M |
| Capital expenditure | -$-57.7M | -$-77.6M | -$-109.8M | -$-142.5M | -$-103.8M |
| Free cash flow | $273.5M | $51M | $95.3M | $170.9M | $189.5M |
Line items
Line items
Line items
About Ingevity Corporation
Ingevity Corporation (NGVT) is a global provider specializing in the production and distribution of advanced chemical solutions and activated carbon products. The company's reach extends across North America, the Asia Pacific region, Europe, the Middle East, Africa, and South America. Its business operations are organized into two principal divisions: Performance Materials and Performance Chemicals. The Performance Materials segment focuses on the engineering, manufacturing, and sale of chemically activated carbon products, primarily derived from hardwood. These materials are chiefly utilized in gasoline vapor emission control systems for a wide range of vehicles, including cars, motorcycles, trucks, and boats. Beyond automotive applications, this division also supplies various activated carbon products for purification purposes in areas like food, water, beverages, and industrial chemicals. The Performance Chemicals segment covers pavement technologies, industrial specialty products, and engineered polymers. This division creates products sourced from crude tall oil and lignin, which are extracted during the kraft pulping process, as well as caprolactone monomers and their derivatives, synthesized from cyclohexanone and hydrogen peroxide. The extensive applications for these products include warm mix paving, pavement upkeep and refurbishment, and recycling; additives for oil well services, oil production, and downstream applications; alongside components for adhesives, agricultural dispersants, lubricants, printing inks, industrial intermediates, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
- CEO
- David H. Li
- Employees
- 1.5K
- Beta
- 1.17
Included in
Explore
Frequently asked questions
What is the intrinsic value of Ingevity Corporation (NGVT)?
Ingevity Corporation (NGVT) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is NGVT undervalued?
NGVT trades at a price of $53.75 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.